CORINDUS VASCULAR ROBOTICS, INC. (NYSEMKT:CVRS) Files An 8-K Results of Operations and Financial Condition
Item 2.02.
|
Results of Operations and Financial Condition. |
On May 9, 2017, Corindus Vascular Robotics, Inc. (the Company)
issued a press release announcing financial results for the first
quarter ended March 31, 2017. The copy of the press release is
furnished as Exhibit 99.1 to this Current Report on Form 8-K and
is incorporated herein by reference.
The information in this Current Report on Form 8-K (including the
exhibit) is furnished to Item2.02 and shall not be deemed to be
filed for the purposes of Section 18 of the Securities Exchange
Act of 1934, as amended (the Exchange Act), or otherwise subject
to the liabilities of that section. The information in this
Current Report shall not be incorporated by reference into any
filing under the Securities Act of 1933, as amended, or the
Exchange Act, whether made before or after the date of this
Current Report, regardless of any general incorporation language
in the filing.
We do not have, and expressly disclaim, any obligation to release
publicly any updates or any changes in our expectations or any
change in events, conditions, or circumstances on which any
forward-looking statement is based.
The text included with this Current Report on Form 8-K is
available on our website located at www.corindus.com,
although we reserve the right to discontinue that availability at
any time.
| Item 9.01. | Financial Statements and Exhibits. |
(d)Exhibits.
| Exhibit Number | Description |
| 99.1 |
Press Release of Corindus Vascular Robotics, Inc. dated May 9, 2017. |
About CORINDUS VASCULAR ROBOTICS, INC. (NYSEMKT:CVRS)
Corindus Vascular Robotics, Inc. is engaged in robotic-assisted vascular interventions. The Company’s CorPath System is a medical device that brings robotic-assisted precision to radial, coronary and peripheral procedures. The workstation allows the physician greater control and the freedom from wearing heavy lead protective equipment that causes musculoskeletal injuries. With the CorPath System it brings robotic precision to radial and complex interventional procedures to help optimize clinical outcomes and minimize the costs associated with complications of improper stent placement with manual procedures. It operates through the development, marketing and sales of robotic-assisted vascular interventions segment. The CorPath System enables the robotic-assisted control of coronary guidewires and balloon/stent devices from the safety of a radiation-protected, ergonomic interventional cockpit. The CorPath System consists of two components: a bedside unit and an interventional cockpit. CORINDUS VASCULAR ROBOTICS, INC. (NYSEMKT:CVRS) Recent Trading Information
CORINDUS VASCULAR ROBOTICS, INC. (NYSEMKT:CVRS) closed its last trading session up +0.03 at 1.28 with 540,590 shares trading hands.
